Saudi health expert: Having COVID-19 vaccine jabs our only way back to normal lives

Short Url
Updated 30 April 2021
Follow

Saudi health expert: Having COVID-19 vaccine jabs our only way back to normal lives

  • ‘This is a humanitarian cause, for yourself, for the people and for the love of the country’

JEDDAH: Saudi Arabia’s coronavirus disease (COVID-19) vaccine rollout has inoculated more than 25 percent of the population.
Over the past year, the Kingdom has promoted strict protocols to curb the virus until the national vaccine campaign started. Every new vaccine administered is another step to normalcy. Saudi health experts have said that in a bid to return to normal life in the fight against COVID-19, vaccines are a necessity, not a luxury.
“The government placed the safety of their people first and the nation lived through an unsettling new normal. Many have come to realize that life is somewhat back to normal with prayers resumed at mosques and people returning to coffee shops. Many have felt the sense of urgency and rushed to take the vaccine. We can’t afford another hit,” infectious disease consultant Dr. Nezar Bahabri told Arab News.
He added: “The vaccines are the only way to return back to our normal lives. This is a humanitarian cause, for yourself, for the people and for the love of the country.”
After the World Health Organization declared a pandemic in March 2020, Saudi Arabia protected its health system and prevented the spread of the virus by imposing flight bans, lockdowns, curfews and making social distancing and the wearing of masks mandatory. The daily case count never made it past 5,000 cases per day, thanks to government efforts supported by the public’s adherence. 
The numbers declined, restrictions were loosened and people began to get a grasp of their new reality, gradually and carefully. 
But to return to the old normal, COVID-19 vaccines were critical. 
By ramping up vaccinations, suffering communities could rebuild foundations for a prosperous and lasting recovery. 
Saudi Arabia supported the global vaccine development and pledged $500 million on vaccine campaigns. The Kingdom gave $150 million to the Global Alliance for Vaccines and Immunizations, $150 million to the Coalition for Epidemic Preparedness and Innovation and $200 million to regional and global programs. 
Through careful planning and accurate timing, the first batch of Pfizer/BioNtech COVID-19 vaccines arrived in the Kingdom in early December, shortly followed by the Oxford-AstraZeneca vaccine. The national vaccine rollout was already in full swing after both vaccines were cleared for public use by the Saudi Food and Drug Authority, and news of two more jabs pending approval built on hope for a swift recovery.
According to the Saudi Health Council, 5,000 Saudi residents received their first doses on Dec. 18, 2020. By March 3, 1 million people had been inoculated. 

But 1 million is not enough. Late last month, a series of recommendations were put into place by several ministries — notably the Ministry of Hajj and Umrah and the Ministry of Human Resources and Social Development — making it mandatory for employees of certain sensitive sectors to be inoculated or provide weekly negative PCR test results at the expense of the employer.
By March 28, 4 million residents received at least one vaccine dose. The inoculation program picked up speed soon after. Vaccines were administered at a rate of 1 million doses every 5 to 7 days.
“The vaccine is the tool that will reopen doors again. Government sectors have made it mandatory to protect the people, the consequences for those refusing to take it will bear a heavy toll.”
Bahabri said that many people refusing to take the vaccine would start a series of unfortunate events that could lead to a possible collapse in the healthcare system, something that the Kingdom has successfully prevented since the start of the pandemic. 
Vaccine hesitancy has been hardened by false claims spreading on social media. Efforts were made to prevent false rumors being shared, such as fines and imprisonment when a perpetrator was caught. 

BACKGROUND

• After the World Health Organization declared a pandemic in March 2020, Saudi Arabia protected its health system and prevented the spread of the virus by imposing flight bans, lockdowns, curfews and making social distancing and the wearing of masks mandatory. The daily case count never made it past 5,000 cases per day, thanks to government efforts supported by the public’s adherence. 

• Saudi Arabia supported the global vaccine development and pledged $500 million on vaccine campaigns. The Kingdom gave $150 million to the Global Alliance for Vaccines and Immunizations, $150 million to the Coalition for Epidemic Preparedness and Innovation and $200 million to regional and global programs.

“It’s not so much hesitancy anymore, it’s negligence,” said Bahabri, adding: “It’s unfortunate to see this happening. It’s un-Islamic, but fortunately people are listening and heeding the call. It’s an important step, for the citizens and community alike.”
Abu-Talal A., a retired businessman in Jeddah, told Arab News that the past year was difficult with the absence of his children and grandchildren. Having lost his wife nearly five years ago, he blamed his fear of the vaccine on conspiracy theorists and anti-vaccine activists that flooded his social media feeds.
“I trust the experts, I trust the government but I do not know what to expect if I take it.”
He told Arab News that posts by skeptics claiming to have hard evidence that the pandemic is a hoax and that the inoculation would damage his genetics put him in a bubble he said was hard to get out of.
“It’s a scary time and though I resisted for long, my son eventually made the appointment for me and the decision was a fait accompli that rendered me speechless. My children are careful but they want me safe. The support, the internet and transparency in relaying information helps… This has gone long enough and we all need to live normally again,” he said.


Healthcare must be ‘proactive’ says Hevolution exec

Updated 4 sec ago
Follow

Healthcare must be ‘proactive’ says Hevolution exec

  • Princess Dr. Haya bint Khaled bin Bandar Al-Saud spoke to Arab News at a presentation of its second Global Healthspan Report

RIYADH: Healthcare needs to shift to a global model that targets preventing disease rather than treating it, a senior executive from the Saudi-funded Hevolution Foundation told Arab News.

The senior vice president of research of Hevolution, Princess Dr. Haya bint Khaled bin Bandar Al-Saud, spoke to Arab News at a presentation of its second Global Healthspan Report at the nonprofit’s headquarters in Riyadh’s KAFD on Wednesday.

“People have to be aware, healthcare has to change its way of thinking, because it’s a must,” she said. “We cannot be reactive anymore, we have to be proactive.

“And this has to start earlier in the education of health professionals, and third, someone needs to take this to the global agenda. The general public needs to know that this is a reality.” 

Launching its report, Hevolution called for urgent global action to treat healthy aging as an economic imperative, where prevention, not disease, drives prosperity.

The organization focuses on healthspan research, or extending the healthy human lifespan.

The findings of the report centered around five main areas; rising awareness and public demand, breakthrough science and new therapies, AI and data revolution, investment momentum and gaps and economic and policy imperatives.

The report detailed the momentum of a new healthspan era where science, technology and public awareness are converging, but momentum alone is not enough.

Al-Saud explained that achieving equitable and evidence-based progress would require coordinated leadership from scientists, policymakers and investors alike.

“Today, science and societal cause has to be integrated, meaning the public needs to know that everything that we are investing in is for the general population, not just on a local level but on a global level,” she said.

The report surveyed 23 countries on the awareness of healthspan, which found that two-thirds of healthcare professionals now receive patient inquiries about healthspan interventions at least once a month, with one-third reporting them weekly.

Al-Saud highlighted that the report also found that 80 per cent of citizens believed governments should fund preventive care programs, while 39 per cent expressed concern about inequality in access.

“Awareness is the most important thing. This subject touches every single one of us, every single one of us has a story that this relates to, whether a grandparent, sick parent, or us,” she said.

Under artificial intelligence the report found that 74 per cent of experts believe AI will transform healthspan R&D and healthcare delivery, yet 26–30 per cent remain opposed to AI in diagnostics, reflecting an ongoing trust and ethics gap.

The report detailed that 59 per cent of investors cite lack of awareness as the top barrier while 46 per cent point to limited experts, unclear evidence and weak regulatory frameworks.

“Between 2022 and 2024 the investments in healthspan has doubled, it’s estimated to be $7 billion invested in finding interventions in healthspan globally,” Al-Saud said.

Investment in healthspan reached $7.33 billion in 2024, up from $3.48 billion the previous year. The average deal size has grown 77 per cent since 2020, signaling maturing confidence in the sector.

“Hevolution Foundation remains the world’s largest philanthropic backer of aging biology and healthspan science, with $400 million allocated in over 230 grants, 25 partnerships, and four biotech ventures,” Al-Saud said.

According to a report from Hevolution, expanding could deliver up to $220 billion annually in productivity gains, and every $1 invested in prevention could yield $16 in returns.

“We always want to support scientists but the end-consumer is the general public,” Al-Saud said.

Hevolution has remained true to its mission since its foundation; to extend healthy human lifespan for all, mobilizing the science, innovation and investment needed to make healthier longer lives a shared global reality.

Established by royal decree in 2018 and launched in 2021, Hevolution Foundation is a non-profit organization that focuses on accelerating independent research and entrepreneurship in the emerging field of healthspan science.

Headquartered in Riyadh, Saudi Arabia, with a North American hub in Boston, the foundation says it has plans for further international expansion, and has set key goals and targets to advance its vision and mission.